💉 Adults with type 1 #diabetes had a significant decline in time in range 3 months after they discontinued semaglutide therapy.
Learn more about the ADJUST-T1D extension study 👇
@BreakthroughT1D @IUMedSchool @GoHealio
vist.ly/5pgx3
Endocrine Today retweeted
‼️New on @GoHealio‼️
A phase 2 clinical trial investigating EC-104, a fluocinolone acetonide extended-release intravitreal implant for #DiabeticMacularEdema, met its primary endpoint.
Read more: 🔗
vist.ly/5pdte
🚨 The rules are simple: No Google, no ChatGPT, no Claude. Just you vs. WORD DOC. Think you can solve it?
Play now: vist.ly/5pd8g
#WordChallenge #WORDDOC
Endocrine Today retweeted
🗣️ “You can do things to at least delay the onset [of dementia]. And that’s very powerful as a clinical tool,” Rachel Whitmer, PhD, said at #CMHC2026.
@CMHC_CME @EndocrineToday @GoHealio @healioneurology @HealioPsych
vist.ly/5paw7
Endocrine Today retweeted
HOT OFF THE PRESS
Read our #HealioExclusive on how physicians and turn patients’ questions about online misinformation into an opportunity to build trust and educate.
vist.ly/5pch6
@GoHealio @EndocrineToday @HMethodistCV @CleClinicHVTI @DCRINews
♀️ The generic version of Climara Pro, which was recently approved by the @US_FDA, is indicated for the treatment of moderate to severe vasomotor symptoms during #menopause and for prevention of postmenopausal osteoporosis.
@ZydusUniverse @healiowomen
vist.ly/5pcp2
🎥 Don’t miss this @GoHealio exclusive interview with Dr. Tandy Aye of @StanfordMed at @BreakthroughT1D Clinical and Research Congress.
Dr. Aye discusses the pediatric endocrinologist shortage in the U.S. and what can be done about it.
vist.ly/5pbnn
Endocrine Today retweeted
Together with community organizations and local nonprofits, @DaVitaDoc conducts neighborhood events to screen for hypertension, diabetes and #kidneydisease.
Here’s what they’ve learned 👇
vist.ly/5p7xb
🚨 The @US_FDA has approved the first generic for Climara Pro, a once-weekly transdermal hormone therapy patch.
Read more about this new approval ⬇️
@ZydusUniverse @healiowomen @GoHealio
vist.ly/5p8js
📢 “A thyroglobulin below the cutoff should not be read as remission on its own. It needs to be paired with a neck ultrasound.”
Dr. Mayumi Endo discusses how thyroglobulin levels may not indicate #cancer remission for adults with higher-risk cancer.
vist.ly/5p7dp
Endocrine Today retweeted
🔎 The U.S. POINTER study “powerfully” showed that lifestyle interventions can improve cognitive function in older adults who hadn’t eaten right and exercised, Rachel Whitmer, PhD, said at #CMHC2026.
@CMHC_CME @GoHealio @EndocrineToday @healioneurology
vist.ly/5p6vn
⚠️ @acog expanded its guidance on treating #menopausal symptoms like hot flashes and night sweats, strongly recommending systematic hormone therapy. ♀️
The guidance also highlights several nonhormonal and nonpharmacologic options, like #SSRIs. ⬇️
vist.ly/5nk96
Endocrine Today retweeted
⚖️ Weighing in from #ACG2026: “#BMI does not tell the whole story in MASLD,” says Dr. Sarpong Boateng @SarpB44 @ynhhealth
Body roundness index better predicted long-term mortality, uncovering hidden risk even in lean, non-obese patients with #MASLD vist.ly/5nrtt
Endocrine Today retweeted
For #ophthalmologists, occupational pain can start early.👀
In this @GoHealio exclusive feature, experts dive into how good #ergonomics can save doctors from all specialties from musculoskeletal pain and injuries.
Preserve your body for a long career!🔗
vist.ly/5n2qk
Endocrine Today retweeted
Vascular pathology and changes in midlife play a major role in brain health later in life, suggesting that reducing cardiometabolic risk factors may lower risk for dementia and Alzheimer’s disease, according to a speaker at #CMHC2026.
@CMHC_CME @GoHealio
vist.ly/5nz2f
🏥 A thyroglobulin cutoff of 2.5 ng/mL or less may not indicate #cancer remission for adults with intermediate-low- or higher-risk #thyroid cancer.
@EndoMedia @UWEndocrinology @HemOncToday
vist.ly/5nzjs
🔎 In a 13-week trial, twiist provided a range of glycemic benefits for adults with type 2 #diabetes, including
📌 improved time in range
📌 lower HbA1c
📌 no severe hypoglycemia
The system is now cleared for use in the type 2 diabetes population.
vist.ly/5nwj7
📹 Did you miss our #HealioExclusive video with Dr. Chantal Mathieu of @KU_Leuven at the @BreakthroughT1D Clinical and Research Congress?
If so, be sure to check it out 👇
@GoHealio
vist.ly/5nw7b
📖 A @DiabetologiaJnl consensus report details ways healthcare systems can start screening all people for type 1 #diabetes.
We spoke to Anastasia Albanese-O’Neill of @BreakthroughT1D about this new movement.
@GoHealio @IDinChildren
vist.ly/5nusp
🗣️“Standardize, centralize, optimize … may work in a factory, but is not applicable to all aspects of a medical practice,” Yul Ejnes, MD, tells @JonathanLeffert in the latest Putting It Into Practice on @GoHealio.
vist.ly/5nt2x






